Search results for "Venous thromboembolism"
For inpatient VTE prevention, rivaroxaban noninferior to enoxaparin
Rivaroxaban is noninferior to enoxaparin for standard-duration venous thromboembolism (VTE) prophylaxis in acutely ill patients, a new study found.
https://acphospitalist.acponline.org/weekly/archives/2013/02/13/3.htm
13 Feb 2013
Cases from St. Joseph Mercy Ann Arbor
Amyloid cardiomyopathy, Haemophilus influenzae infection, metastatic melanoma and more.
https://acphospitalist.acponline.org/archives/2017/09/brief-case-st-joseph-mercy-ann-arbor.htm
15 Sep 2017
Recent Research
Thrombolytic therapy and acute PE, bleeding risk in patients on warfarin before MI, and more.
https://acphospitalist.acponline.org/archives/2012/07/rr.htm
15 Jul 2012
May 2007
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2007/05/
Intermittent pneumatic compression helps reduce VTE risk
Intermittent pneumatic compression (IPC) to the lower limbs can reduce venous thromboembolism (VTE) risk in hospitalized patients and is especially effective when combined with pharmacologic thromboprophylaxis, a new meta-analysis found.
https://acphospitalist.acponline.org/weekly/archives/2013/07/24/1.htm
24 Jul 2013
Infection, other factors may increase risk for VTE hospitalization
Infection, treatment with erythropoiesis-stimulating agents, and blood transfusion may increase risk for hospitalization due to venous thromboembolism (VTE), according to a new study.
https://acphospitalist.acponline.org/weekly/archives/2012/04/11/2.htm
11 Apr 2012
Longer venous thromboprophylaxis after total hip replacement decreases events, ups minor bleeding risk
Venous thromboprophylaxis for 21 days or more after total hip replacement lowers risk for venous thromboembolism, pulmonary embolism and deep venous thrombosis while increasing the risk for minor bleeding, according to a new study.
https://acphospitalist.acponline.org/weekly/archives/2012/03/21/3.htm
21 Mar 2012
Risk score helps determine 30-day mortality in patients with cancer and PE
A simple risk score may help determine 30-day mortality risk in patients with active cancer and acute pulmonary embolism (PE), a new study has found.
https://acphospitalist.acponline.org/weekly/archives/2012/08/01/4.htm
1 Aug 2012
UFH, LMWH similar in cost, efficacy for VTE prophylaxis
Unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) have similar costs and effectiveness for venous thromboembolism (VTE) prophylaxis, but LMWH is associated with fewer complications, a new study found.
https://acphospitalist.acponline.org/weekly/archives/2012/04/11/3.htm
11 Apr 2012
NIH guidelines on anticoagulation in COVID-19; research on statin use, omicron variant
The NIH updated its guidelines to address anticoagulation in COVID-19 inpatients, treatment with atorvastatin did not appear to improve outcomes in the ICU, and several studies looked at characteristics of omicron.
https://acphospitalist.acponline.org/archives/2022/01/12/free/nih-guidelines-on-anticoagulation-research-on-statins-and-COVID-19.htm
12 Jan 2022